Picture of Hyphens Pharma International logo

1J5 — Hyphens Pharma International Share Price

0.000.00%
sg flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSuper Stock

Momentum

Relative Strength (%)
1m+11.21%
3m+19.9%
6m+20.01%
1yr+22.12%
Volume Change (%)
10d/3m-53.49%
Price vs... (%)
52w High-7.58%
50d MA+2.14%
200d MA+2.16%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)11.28
PEG Ratio (f)1.09
EPS Growth (f)11.58%
Dividend Yield (f)2.62%
Valuation (ttm)IndustryMarket
Price to Book Value1.72
Price to Tang. Book2.73
Price to Free Cashflow18.1
Price to Sales0.75
EV to EBITDA7.39

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital16.17%
Return on Equity13.45%
Operating Margin7.17%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total RevenueSG$m112.65120.93119.44123.7125.88145151.44.51%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+10.88-18.21+4.87-11.4+15.87+16.38+7.69n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for 1J5

What's in store for shares in Hyphens Pharma International? background image

What's in store for shares in Hyphens Pharma International?

Shares in Hyphens Pharma International (SGX:1J5) are currently trading at 0.345 but a key question for investors is how the economic uncertainty caused by Covid-19 will affect the price. The answer comes down to judging whether it is w...

Can Hyphens Pharma International resist market uncertainty? background image

Can Hyphens Pharma International resist market uncertainty?

Economic shockwaves caused by Covid-19 have plunged stock markets into turmoil, but some shares are better able to absorb this volatility than others - and Hyphens Pharma International (SGX:1J5) could be one of them. To understand why...

Stock market volatility: Here's a small-cap worth a closer look background image

Stock market volatility: Here's a small-cap worth a closer look

Shares in Hyphens Pharma International (SGX:1J5) are currently trading at 0.3 but the question for investors is how much the market chaos of 2020 will impact its share price. The answer comes down to judging whether Hyphens Pharma Inte...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Hyphens Pharma International EPS forecast chart

Profile Summary

Hyphens Pharma International Limited is a Singapore-based investment holding company. The Company’s principal activity is the provision of management services. The Company operates through three segments: Specialty Pharma Principals, Proprietary Brands, and Medical Hypermart and Digital. Specialty pharma principals segment is in the business of marketing and selling a range of pharmaceutical products with exclusivity in the relevant the Association of Southeast Asian Nations countries. Proprietary brands segment is in the business of developing, marketing and selling its own range of dermatological products and health supplement products. Medical hypermart and digital segment is a wholesaler of pharmaceuticals and medical supplies in Singapore, which the Company positions itself as a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies.

Directors

    Last Annual
    December 31st, 2021
    Last Interim
    December 31st, 2021
    Incorporated
    December 12th, 2017
    Public Since
    May 18th, 2018
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    sg flag iconSingapore Exchange Securities Trading Ltd
    Shares in Issue
    308,776,200

    1J5 Share Price Performance

    Upcoming Events for 1J5

    Similar to 1J5

    Picture of Haw Par logo

    Haw Par

    sg flag iconSingapore Exchange Securities Trading Ltd

    Picture of IX Biopharma logo

    IX Biopharma

    sg flag iconSingapore Exchange Securities Trading Ltd

    Picture of Pharmesis International logo

    Pharmesis International

    sg flag iconSingapore Exchange Securities Trading Ltd

    Picture of Suntar Eco-City logo

    Suntar Eco-City

    sg flag iconSingapore Exchange Securities Trading Ltd

    FAQ

    Or unlock with your email

    Or unlock with your email